Identification of TLR downstream pathways in stroke patients
Related Experiment Video
Updated: May 10, 2026

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
Dean Wu1, Yuan-Chii G Lee2, Hsing-Cheng Liu3
1Department of Neurology, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan; Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan.
Objective:
Toll-like receptors (TLRs) are important molecules for detecting both pathogen invasion and tissue damage. The expression of TLR4 is upregulated in ischemic stroke, at least in the subacute stage. However, the TLR downstream pathways in the context of stroke have not been well studied in previous research. The purpose of this study is to elucidate the TLR4 downstream pathways following ischemic stroke.
Design And Methods:
In this study, 12 ischemic stroke patients and 12 controls were selected from among 89 ischemic stroke patients and 166 controls. The chosen subjects had the highest levels of TLR4 mRNA in the peripheral blood. The differences in the TLR downstream signaling pathways, which were studied by using an RT2 Profiler TM PCR array system (Qiagen), were analyzed. The differentially expressed genes were analyzed by using GeneSpring GX and visualized based on the TLR pathways in the Kyoto Encyclopedia of Genes and Genomes (KEGG).
Results:
The genes upregulated in stroke patients were found to be involved in the MyD88-independent pathway and in UBE2V1-TRAF6 ubiquitin-mediated proteolysis. The genes were more expressed in extracellular space, receptor binding, and cytokine receptor binding by use of gene ontology (GO) terms than in control patients.
Conclusions:
We found that the MyD88-independent pathway and the ubiquitin-mediated proteolysis pathway, especially TRAF6, may be the most vital molecules among TLR downstream pathways in incidences of ischemic stroke.
Insights
Toll-like receptor 4 (TLR4) downstream pathways, particularly the MyD88-independent and ubiquitin-mediated proteolysis pathways involving TRAF6, are crucial in ischemic stroke. Understanding these pathways aids in stroke research.
Area of Science:
- Immunology
- Neuroscience
- Molecular Biology
Background:
- Toll-like receptors (TLRs) detect pathogen invasion and tissue damage.
- TLR4 expression is elevated in ischemic stroke, but its downstream pathways remain understudied.
- Investigating TLR4 signaling is key to understanding stroke pathophysiology.
Purpose of the Study:
- To elucidate the specific TLR4 downstream signaling pathways activated in ischemic stroke.
- To identify key molecular players in TLR4-mediated responses post-stroke.
Main Methods:
- Analysis of peripheral blood from 12 ischemic stroke patients and 12 controls with high TLR4 mRNA levels.
- Utilized RT2 Profiler™ PCR array system to study TLR downstream signaling pathways.
- GeneSpring GX software and KEGG pathway analysis for differentially expressed genes.
Main Results:
- Upregulated genes in stroke patients were linked to the MyD88-independent pathway and UBE2V1-TRAF6 ubiquitin-mediated proteolysis.
- Gene Ontology analysis revealed enrichment in extracellular space, receptor binding, and cytokine receptor binding.
- Significant differences in gene expression patterns were observed compared to controls.
Conclusions:
- The MyD88-independent pathway and TRAF6-mediated ubiquitin proteolysis are critical in ischemic stroke.
- These pathways represent vital molecular targets for future stroke research and therapeutic strategies.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology